Blacksmith Medicines receives European patent for LpxC-targeting antibacterial compounds: San Diego, California Tuesday, November 25, 2025, 16:00 Hrs [IST] Blacksmith Medicines, I ...

Blacksmith Medicines, Inc. (Blacksmith), a leading biopharma dedicated to discovering and developing therapeutics targeting metalloenzymes, today announced that the European Patent Office has issued a ...

For decades, pharmaceutical companies have been using bacteria found in soil and water to chemically convert steroids into ...

In natural environments, bacteria rarely live as free-swimming cells but are attached to surfaces as biofilms in medical ...

Pfizer announced the introduction of a novel treatment in the United Arab Emirates for adult patients with serious ...

GSK is investing £45m with the Fleming Initiative to launch six research programmes using cutting-edge AI to tackle ...

This newly introduced therapy is designed to restore effectiveness against some of the most resistant pathogens ...

GSK funding has been allocated to new research programmes combining expertise and using cutting edge AI technology to ...

The antimicrobial treatment could help producers reduce chemical use in processing plants and extend shelf life of poultry ...

If you are also suffering from a bacterial infection and have waited long enough for its natural recovery you may need a Swab ...

A mechanosensitive fluorescent probe visualises and quantifies the mechanical stress on bacterial membranes upon contact with ...